Ignite Creation Date:
2024-05-06 @ 7:06 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05898828
Status:
WITHDRAWN
Last Update Posted:
2024-07-15
First Post:
2023-06-09
Brief Title:
Phase III Evaluation of a Cancer Lysate Vaccine and MontanideR ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-18
Start Date Type:
ESTIMATED
Primary Completion Date:
2034-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2036-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-09
First Submit QC Date:
June 9 2023
Study First Post Date:
2023-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-02
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED